Pills 2 (2)
Hollis Johnson/Business Insider

Hello,

Today in healthcare news: Coronavirus-fighting booster shots are expected in the UK by the fall, an analysis around why delaying second doses might be worthwhile, and the US paid $44 million to Deloitte for a glitchy vaccine appointment system


Coronavirus vaccine trial UK
Kirsty O'Connor/PA Images via Getty Images

Booster shots are likely in the UK this fall to combat coronavirus variants – a sign vaccines may become an annual affair

Read the full story from Aylin Woodward here>> 


fauci questions
Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, during a White House press briefing on January 21, 2021 in Washington DC.
Alex Wong/Getty Images

Scientists, including Fauci, are facing off over whether to delay 2nd vaccine doses. Here’s why the risk of more mutations from delaying shots may ultimately be worth it.

Read the full analysis from Dr. Catherine Schuster-Bruce here>>


covid vaccine card cdc
ICU nurse Megan Tschacher shows off her vaccination card at UC Health Poudre Valley Hospital in Fort Collins, Colorado on December 14, 2020.
Helen H. Richardson/MediaNews Group/The Denver Post/Getty Images

The US paid Deloitte $44 million for a vaccine appointment system laden with glitches. Some states are scrambling for an alternative.

Read the full story from Aria Bendix here>>


More stories we're reading: 


- Lydia

Read the original article on Business Insider